Dr. Gary Garber

IPAC Physician

Photo of Dr. Gary Garber

"I have worked in the hospital and academic/university environment for years. PHO provides the opportunity to have an impact on patient care while working with exciting and motivated colleagues to achieve a common goal of improving the health of Ontarians."

Areas of Expertise

  • infectious diseases
  • infection prevention and control
  • HIV
  • public health
  • viral hepatitis
  • sexually transmitted infection (Trichomonas vaginalis)


Infectious Diseases Physician, The Ottawa Hospital

Professor, Department of Medicine, University of Ottawa and University of Toronto

Cross Appointment: School of Epidemiology & Public Health, University of Ottawa

Member, School of Graduate Studies, University of Ottawa

Associate Scientist, Chronic Disease, Ottawa Hospital Research Institute

Academic Degrees and Accreditations

  • Doctor of Medicine, University of Calgary
  • Fellow, The Royal College of Physicians of Canada, Internal Medicine
  • Diplomate, The American College of Physicians
  • Certificate of Special Competence (Infectious Diseases), The Royal College of Physicians of Canada
  • Fellow, The American College of Physicians
  • Fellow, The Infectious Disease Society of America
  • Canadian Certified Physician Executive

PHO Research Interests

  • Infection prevention and control
  • Antimicrobial stewardship
  • Viral hepatitis
  • Multidisciplinary care of hard to serve populations
  • Management of nosocomial infections in immunocompromised individuals (HIV, care)

PHO Research Activities

  • Vancomycin-resistant Enterococci (VRE) bacteremia: Impact on discontinuation of screening in four teaching hospitals in Ontario.
  • C. Difficile: Where is the reservoir of infection?
  • Development of a health care-associated infections (HAI) surveillance program for Ontario.
  • Seroprevalence of hepatitis C in Ontario.
  • Improving antimicrobial use in long-term care

Selected Publications

  1. Johnstone J, Chen C, Rosella L, Adomako K, Policarpio ME, Lam F, Prematunge C, Garber G; Ontario VRE Investigators. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada. Am J Infect Control. 2018 Jun 11 [Epub ahead of print].
  2. Langford BJ, Wu JH, Brown KA, Wang X, Leung V, Tan C, Garber G, et al. Assessing the impact of antibiotic stewardship program elements on antibiotic use across acute-care hospitals: an observational study. Infect Control Hosp Epidemiol. 2018;39(8):941-6.
  3. Bolotin S, Feld JJ, Garber G, William WWL, Guerra FM, Mazzulli T. Population-based estimate of hepatitis C virus prevalence in Ontario, Canada. PLoS One. 2018;13(1):e0191184.
  4. Johnstone J, Policarpio ME, Lam F, Adomako K, Prematunge C, Nadolny E, Li Y, Brown K, Kerr E, Garber GRates of blood cultures positive for vancomycin-resistant Enterococcus in Ontario: a quasi-experimental study. CMAJ Open. 2017;5:E273-80.
  5. Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE. Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. CMAJ. 2016;188(8):567-74.

View more publications by Dr. Gary Garber on PubMed.gov

Chat icon



Updated 28 July 2020